AU2003228193B2 - Method for albumin purification - Google Patents

Method for albumin purification Download PDF

Info

Publication number
AU2003228193B2
AU2003228193B2 AU2003228193A AU2003228193A AU2003228193B2 AU 2003228193 B2 AU2003228193 B2 AU 2003228193B2 AU 2003228193 A AU2003228193 A AU 2003228193A AU 2003228193 A AU2003228193 A AU 2003228193A AU 2003228193 B2 AU2003228193 B2 AU 2003228193B2
Authority
AU
Australia
Prior art keywords
matrix
rhsa
ccs
cation exchange
cation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2003228193A
Other languages
English (en)
Other versions
AU2003228193A1 (en
Inventor
Makonnen Belew
Mei Yan Li
Wei Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NORTH CHINA PHARMACEUTICAL GROUP Corp
Global Life Sciences Solutions USA LLC
Original Assignee
NORTH CHINA PHARMACEUTICAL GROUP CORP
GE Healthcare Bio Sciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NORTH CHINA PHARMACEUTICAL GROUP CORP, GE Healthcare Bio Sciences Corp filed Critical NORTH CHINA PHARMACEUTICAL GROUP CORP
Publication of AU2003228193A1 publication Critical patent/AU2003228193A1/en
Assigned to GE HEALTHCARE BIO-SCIENCES AB, NORTH CHINA PHARMACEUTICAL GROUP CORPORATION reassignment GE HEALTHCARE BIO-SCIENCES AB Request for Assignment Assignors: AMERSHAM BIOSCIENCES AB, NORTH CHINA PHARMACEUTICAL GROUP CORPORATION
Application granted granted Critical
Publication of AU2003228193B2 publication Critical patent/AU2003228193B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2003228193A 2002-05-15 2003-05-09 Method for albumin purification Ceased AU2003228193B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0201518-8 2002-05-15
SE0201518A SE526227C2 (sv) 2002-05-15 2002-05-15 Metod för rening av rekombinant humant serumalbumin
PCT/SE2003/000766 WO2003097692A1 (en) 2002-05-15 2003-05-09 Method for albumin purification

Publications (2)

Publication Number Publication Date
AU2003228193A1 AU2003228193A1 (en) 2003-12-02
AU2003228193B2 true AU2003228193B2 (en) 2009-05-07

Family

ID=20287916

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2003228193A Ceased AU2003228193B2 (en) 2002-05-15 2003-05-09 Method for albumin purification
AU2003232704A Abandoned AU2003232704A1 (en) 2002-05-15 2003-05-15 Method, use and kit for separating albumin from contaminants in a liquid

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2003232704A Abandoned AU2003232704A1 (en) 2002-05-15 2003-05-15 Method, use and kit for separating albumin from contaminants in a liquid

Country Status (13)

Country Link
US (2) US7423124B2 (https=)
EP (2) EP1504031B1 (https=)
JP (2) JP2006502098A (https=)
CN (1) CN100463921C (https=)
AT (1) ATE335006T1 (https=)
AU (2) AU2003228193B2 (https=)
BR (2) BRPI0309992B1 (https=)
CA (2) CA2483612A1 (https=)
DE (1) DE60307262T2 (https=)
ES (1) ES2268362T3 (https=)
IL (1) IL164844A (https=)
SE (1) SE526227C2 (https=)
WO (2) WO2003097692A1 (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8802146B2 (en) * 1998-11-06 2014-08-12 Neomend, Inc. Systems, methods, and compositions for prevention of tissue adhesion
SI1599463T1 (sl) * 2003-01-28 2013-10-30 E.I. Du Pont De Nemours And Company Ciano antranilamidni insekticidi
CA2514981A1 (en) * 2003-03-12 2004-09-23 Fresenius Kabi Deutschland Gmbh Use of recombinant albumin in dialysis after liver failure
DK2100904T3 (da) * 2004-04-23 2010-11-08 Conjuchem Biotechnologies Inc Fast fase til anvendelse i en fremgangsmåde til rensning af albuminkonjugater
CN1854155B (zh) * 2005-04-29 2010-11-17 华北制药集团新药研究开发有限责任公司 一种纯化rHSA的方法
CL2008002054A1 (es) * 2007-07-17 2009-05-29 Hoffmann La Roche Metodo para la regeneracion de una columna de cromatografia de intercambio cationico despues de la elusion de eritropoyetina monopeguilada y metodo para obtener una eritropoyetina monopeguilada, incorporando el metodo de regeneracion de la columna de intercambio cationico.
CL2008002053A1 (es) * 2007-07-17 2009-05-22 Hoffmann La Roche Metodo para la purificacion de una eritropoyetina monopeguilada (epompeg) que consiste en proporcionar una solucion que contiene eritropoyetina mono, poli y no peguilada y hacerla pasar por dos pasos de cromatografia de intercambio cationico y metodo para producir epo mpeg que incluye metodo de purificacion.
CN101978268B (zh) * 2008-03-31 2014-04-23 积水医疗株式会社 纯化血清白蛋白及免疫学测定方法
US8753868B2 (en) 2008-08-04 2014-06-17 General Electric Company Method and system for selective isolation of target biological molecules in a general purpose system
CN101768206B (zh) * 2008-12-31 2013-05-15 华北制药集团新药研究开发有限责任公司 一种重组人血清白蛋白的纯化方法及其应用
CA2752729A1 (en) 2009-02-20 2010-08-26 Ventria Bioscience Cell culture media containing combinations of proteins
EP4492053A3 (en) * 2010-05-25 2025-03-19 F. Hoffmann-La Roche AG Methods of purifying polypeptides
CN102127164B (zh) 2010-12-20 2013-01-30 武汉禾元生物科技有限公司 一种从水稻种子中提取重组人血清白蛋白的方法
CN102532254B (zh) * 2010-12-24 2015-06-24 武汉禾元生物科技股份有限公司 一种从水稻种子中分离纯化重组人血清白蛋白的方法
CN104812491B (zh) * 2012-03-08 2018-06-19 生物辐射实验室股份有限公司 阴离子交换-疏水性混合模式
CN103880947B (zh) 2012-12-21 2016-01-13 武汉禾元生物科技股份有限公司 一种分离纯化高纯度重组人血清白蛋白的层析方法
CN103923211A (zh) * 2014-05-08 2014-07-16 齐智 一种医药级重组人血清白蛋白的纯化方法
EP4424326A3 (en) 2015-06-10 2024-11-13 ImmunityBio, Inc. Modified nk-92 cells for treating cancer
CN106117326A (zh) * 2015-12-09 2016-11-16 烟台大学 一种离心法结合阴离子交换层析介质制备藻红蛋白的方法
CN106146631A (zh) * 2015-12-09 2016-11-23 烟台大学 一种离心技术结合疏水层析介质制备藻红蛋白的方法
CN106117347A (zh) * 2015-12-09 2016-11-16 烟台大学 一种疏水层析制备高纯度藻红蛋白的方法
EP4653865A3 (en) 2019-09-24 2026-02-18 Regeneron Pharmaceuticals, Inc. Systems and methods for chromatography use and regeneration
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
WO2022120547A1 (zh) 2020-12-08 2022-06-16 通化安睿特生物制药股份有限公司 纯化重组蛋白的方法
EP4267210A1 (en) 2020-12-28 2023-11-01 Davol Inc. Reactive dry powdered hemostatic materials comprising a protein and a multifunctionalized modified polyethylene glycol based crosslinking agent
CN113461804A (zh) * 2021-08-09 2021-10-01 山东健通生物科技有限公司 减少重组人血白蛋白发酵过程中色素的方法
CN113880908B (zh) * 2021-08-25 2024-05-14 北京伟德杰生物科技有限公司 纯化重组人血清白蛋白的融合蛋白的方法
CN113735962B (zh) * 2021-08-27 2023-11-10 常熟纳微生物科技有限公司 一种从猪血中纯化重组人血清白蛋白的方法及应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4093612A (en) * 1975-08-04 1978-06-06 Research Corporation Selective removal of albumin from blood fluids and compositions therefore
FR2403098A1 (fr) * 1977-09-19 1979-04-13 Merieux Inst Nouveau materiau capable de fixer de facon reversible des macromolecules biologiques, sa preparation et son application
US5849874A (en) * 1991-07-12 1998-12-15 Gist-Brocades, N.V. Process for the purification of serum albumin
DE69230273T2 (de) * 1991-07-12 2000-05-31 Dsm N.V., Heerlen Verfahren zur Reinigung von Serumalbumin
JPH07102148B2 (ja) * 1992-05-20 1995-11-08 株式会社ミドリ十字 遺伝子操作により得られるヒト血清アルブミンの製造方法、およびそれにより得られるヒト血清アルブミン含有組成物
US5521287A (en) * 1992-05-20 1996-05-28 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
US5440018A (en) * 1992-05-20 1995-08-08 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
CA2116385A1 (en) * 1993-02-25 1994-08-26 Akinori Sumi Human serum albumin and process for producing the same
CA2138349A1 (en) * 1993-12-17 1995-06-18 Welfide Corporation Method for decoloring human serum albumin
CA2157219C (en) 1994-08-31 2010-10-05 Munehiro Noda Process for purifying recombinant human serum albumin
JP3840674B2 (ja) * 1994-08-31 2006-11-01 三菱ウェルファーマ株式会社 遺伝子操作に由来するヒト血清アルブミンの精製方法
GB9902000D0 (en) * 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
SE0002688D0 (sv) 2000-07-17 2000-07-17 Amersham Pharm Biotech Ab Adsorption method and ligands
JP4798832B2 (ja) * 2000-10-24 2011-10-19 一般財団法人化学及血清療法研究所 ヒト血清アルブミン多量体の除去方法

Also Published As

Publication number Publication date
BRPI0309992B8 (pt) 2023-03-21
AU2003228193A1 (en) 2003-12-02
EP1504032A1 (en) 2005-02-09
ATE335006T1 (de) 2006-08-15
DE60307262D1 (de) 2006-09-14
SE0201518D0 (sv) 2002-05-15
JP4559216B2 (ja) 2010-10-06
JP2006502098A (ja) 2006-01-19
US20050214902A1 (en) 2005-09-29
WO2003097693A1 (en) 2003-11-27
BRPI0309992B1 (pt) 2020-12-22
ES2268362T3 (es) 2007-03-16
CA2483616A1 (en) 2003-11-27
BR0309992A (pt) 2005-03-01
JP2006512283A (ja) 2006-04-13
US7423124B2 (en) 2008-09-09
US7351801B2 (en) 2008-04-01
CN100463921C (zh) 2009-02-25
DE60307262T2 (de) 2007-06-28
IL164844A (en) 2009-09-01
IL164844A0 (en) 2005-12-18
SE526227C2 (sv) 2005-08-02
WO2003097692A1 (en) 2003-11-27
EP1504031B1 (en) 2006-08-02
US20050215765A1 (en) 2005-09-29
AU2003232704A1 (en) 2003-12-02
EP1504031A1 (en) 2005-02-09
CA2483612A1 (en) 2003-11-27
CN1496993A (zh) 2004-05-19

Similar Documents

Publication Publication Date Title
AU2003228193B2 (en) Method for albumin purification
Gaberc-Porekar et al. Perspectives of immobilized-metal affinity chromatography
RU2007132851A (ru) Способ мягкой распределительной хроматографии
CA2395590C (en) Method of producing human serum albumin involving heating step
McCreath et al. Expanded bed affinity chromatography of dehydrogenases from bakers' yeast using dye–ligand perfluoropolymer supports
JP3768485B2 (ja) 血清アルブミンの精製方法
JP2004535197A (ja) 酵素の精製方法およびその方法で製造された精製済み酵素並びに該酵素の用途
KR100847883B1 (ko) 인체 혈청알부민 다량체의 제거방법
JP2024543701A (ja) 突然変異を起こしたプロテインａのｃドメイン及びその適用
EP1681299B1 (en) Methods for purifying highly anionic proteins
Wakefield et al. Isolation of a membrane protein by chromatofocusing: cytochrome b-561 of the adrenal chromaffin granule
JP2002518000A (ja) 血清アルブミンの除去／精製のための方法およびその方法に使用する手段
KR20240135666A (ko) 단백질 a의 b 도메인과 z 도메인 돌연변이체, 및 이의 응용
KR20050016877A (ko) 알부민 정제 방법
CN110770251A (zh) 纯化白蛋白融合蛋白的方法
HUT71326A (en) Purification of kringle containing proteins, and especially t-pa
IE910410A1 (en) A process for purifying lipocortins
NARAYANAN Application of liquid Chromatography to the Purification of Proteins and Peptides
JPS597694B2 (ja) 不活化トロンビンゲルによるアンチトロンビン３の精製法
Lowe Graham zyxwvutsrqponmlkj
JPH05168475A (ja) クロラムフェニコールアセチルトランスフェラーゼの精製方法
JPH11158198A (ja) インターロイキン６レセプターの精製方法

Legal Events

Date Code Title Description
TC Change of applicant's name (sec. 104)

Owner name: NORTH CHINA PHARMACEUTICAL GROUP CORPORATION; GE H

Free format text: FORMER NAME: AMERSHAM BIOSCIENCES AB; NORTH CHINA PHARMACEUTICAL GROUP CORPORATION

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired